Skip to main content

Table 5 Comparison of the DLCO improvement

From: Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China

Improvement of DLCO % predicted value (%)

EJ (+)

(10.5 ± 5.4)

JO-1 (+)

(16.9 ± 9.8)

PL-7 (+)

(9.1 ± 4.5)

PL-12 (+)

(10.0 ± 4.9)

OJ (+)

(10.3 ± 4.8)

JO-1 (+)

0.008

–

–

–

–

PL-7 (+)

0.432

0.011

–

–

–

PL-12 (+)

0.783

0.023

0.312

–

–

OJ (+)

0.907

0.063

0.455

0.903

–